Start
Entdecken
nav.journalClub
Trends
Mehr
synapse
⌘+K
Sprache
Deutsch
Deutsch
March 3, 2026
Open Access
Therapeutic Potential of Tyrosine Kinase Inhibitors in Advanced Thyroid Cancer
PG
Prakash Gangadaran
Kyungpook National University
VS
Vidya Sankarapandian
Kampala International University
RA
Raksa Arun
SRM Institute of Science and Technology
See all
Key Points
Tyrosine kinase inhibitors show a promising therapeutic potential, improving treatment response in advanced thyroid cancer.
Key evidence reveals that patients receiving inhibitors had a remarkable 40% increase in progression-free survival rates.
Observational analysis of treatment outcomes across multiple centers provided insights into drug efficacy.
Findings suggest that integrating these inhibitors into treatment protocols could enhance therapeutic strategies for advanced thyroid cancer.
Read Full Paper
with AI
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Cite This Study
Copy
Gangadaran et al. (Thu,) studied this question.
synapsesocial.com/papers/69a7671bbadf0bb9e87dfa3e
https://doi.org/https://doi.org/10.1007/s11912-026-01736-z
Therapeutisches Potenzial von Tyrosinkinase-Inhibitoren bei fortgeschrittenem Schilddrüsenkrebs | Synapse